Back

Results - Announcements

Sales rise 11.49% to Rs 114.21 crore

Senores Pharmaceuticals consolidated net profit rises 11.86% in the March 2025 quarter

16-May-2025, 08:05
Net profit of Senores Pharmaceuticals rose 11.86% to Rs 17.83 crore in the quarter ended March 2025 as against Rs 15.94 crore during the previous quarter ended March 2024. Sales rose 11.49% to Rs 114.21 crore in the quarter ended March 2025 as against Rs 102.44 crore during the previous quarter ended March 2024.

For the full year,net profit rose 86.20% to Rs 58.56 crore in the year ended March 2025 as against Rs 31.45 crore during the previous year ended March 2024. Sales rose 85.65% to Rs 398.25 crore in the year ended March 2025 as against Rs 214.52 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	114.21	102.44	11	398.25	214.52	86
OPM %	17.02	21.86	-	22.52	19.39	-
PBDT	25.91	21.32	22	87.41	34.97	150
PBT	20.68	17.61	17	70.57	24.95	183
NP	17.83	15.94	12	58.56	31.45	86